Biogen · 8 hours ago
Co-op, Analytical Development Biologics
Biogen is a mid-sized biotechnology company committed to excellence and innovation. They are seeking a motivated co-op to join the Analytical Development Biologics group in Cambridge, MA, to develop and optimize analytical methods for biologics. The role focuses on characterizing and quantifying host cell proteins using LC-MS techniques to support process development and cross-functional teams.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Develop and optimize LC-MS based methods to characterize and quantify host cell proteins in biologics
Execute the developed LC-MS HCP method to provide decision-enabling information to the process development and other cross-functional teams
Qualification
Required
Knowledge and experience with sample preparation techniques for mass-spectrometry based proteomics approaches
Hands-on experience with mass-spectrometry instruments and associated high performance liquid chromatography
Familiarity with common proteomics software tools, such as Proteome Discoverer, MaxQuant and Skyline
Legal authorization to work in the U.S
At least 18 years of age prior to the scheduled start date
Currently enrolled in an accredited community college, college, university or skills program/apprenticeship
PhD or Masters students
Majoring in: Biochemistry, Chemistry, Biological/Biomedical Engineering, Pharmaceutical Sciences, or a related field
Benefits
Company paid holidays
Commuter benefits
Employee Resource Groups participation
80 hours of sick time per calendar year
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Recent News
2026-01-13
2026-01-13
2026-01-13
Company data provided by crunchbase